Generalized metabolic bone disease in Neurofibromatosis type I - Test2 - elhamkhani - TriplyDB

Generalized metabolic bone disease in Neurofibromatosis type I

Generalized metabolic bone disease in Neurofibromatosis type I

http://www.wikidata.org/entity/Q30841192

about

Optimizing biologically targeted clinical trials for neurofibromatosis.Neurofibromatosis: chronological history and current issues.Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography.Bone mineral density in children and young adults with neurofibromatosis type 1 Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.Bone resorption in syndromes of the Ras/MAPK pathway.Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1 Vitamin D Status and VDR Genotype in NF1 Patients: A Case-Control Study from Southern Brazil.c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.A differential diagnosis of inherited endocrine tumors and their tumor counterparts Secondary Knee Osteoarthritis due to Neurofibromatosis Type 1 Treated with above the Knee Amputation: A Case Report The musculoskeletal phenotype of the RASopathies.Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.Could an osteoinductor result in degeneration of a neurofibroma in NF1?A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease).Constitutional bone impairment in Noonan syndrome.The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study.Increased risk of breast cancer in women with NF1.Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1.

P2860

Q30438898-4CB23BD5-A061-403A-A893-367B21BA82CA Q30449267-71A9A9C9-5110-4976-B85C-DF14EE4684FC Q33396860-FEA5A987-F2D1-4B95-8E95-A4347CDD276E Q34045437-F8631C14-FB70-47A5-B324-FE4DE7EB10A9 Q34253927-8517EA26-79E2-419E-A7B3-0EBB1CC0EE8A Q35225250-C7FD796A-04D0-4ADB-B858-5D7EAC8483A6 Q35635487-BEF8DFEA-D3F6-47B3-8B34-0FCC4B64EEE7 Q35635492-9E3B9AD3-614F-4B84-9D80-2F2272DCB2BD Q35804575-E214E8B2-259F-45B0-8D11-0A916D94EFC9 Q36380904-0B3962AD-47F9-474B-8048-131A53F64066 Q37023603-2A8F6CC2-9514-44DC-A6CD-B17656AD5331 Q37044392-D1DB35B0-C909-4DE1-B9C5-8E895FDDE4B4 Q37865455-E529511F-0543-46F1-A2BF-0B0DA69C26F3 Q38757104-4ED412EF-6F06-4D53-8763-10EE6D8FA8C7 Q42736579-A940A18C-748A-4F25-891E-5B5ED23BB327 Q45187619-C9FFDC06-351A-4063-8486-2A29D5F5D883 Q45846222-AE13AF41-E691-4795-9592-8A5354F4D134 Q46292236-930724C7-AECB-4F8A-9747-71E1406BA761 Q52905410-693E7A82-8DC1-4F94-8464-7B6A9744C74B Q53107807-A271FFA1-F923-45D0-8A0F-2C2A272B4402 Q54448633-3E9F2891-511E-4418-9CA7-2ACB2B648FA3 Q55072898-C23B54A5-F57F-4484-BE45-F7FD4A5A2127

P2860

Generalized metabolic bone disease in Neurofibromatosis type I

http://www.wikidata.org/entity/Q30841192

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Generalized metabolic bone disease in Neurofibromatosis type I

@ast

Generalized metabolic bone disease in Neurofibromatosis type I

@en

type

label

Generalized metabolic bone disease in Neurofibromatosis type I

@ast

Generalized metabolic bone disease in Neurofibromatosis type I

@en

prefLabel

Generalized metabolic bone disease in Neurofibromatosis type I

@ast

Generalized metabolic bone disease in Neurofibromatosis type I

@en

P1433

Q30841192-727879CC-28E0-4444-B74B-7505F756F86D

P1476

Q30841192-24447EDC-CAAD-487E-9329-F2D5CD445B23

P2093

Q30841192-11798DD8-5BB8-47BD-9A1D-9EA48FFFBC21

Q30841192-11C8954B-BD60-4C2F-9361-230E78477228

Q30841192-246DEF27-753C-472B-8526-BFE53DB62166

Q30841192-46CA7DDF-6D62-464C-9C52-7546111050E9

Q30841192-4AFB868D-420E-4591-AEF5-C146DFB032B9

Q30841192-4FA5BB34-66A0-477A-9422-78204AF61608

Q30841192-628B1B5C-EEE5-4441-B2B9-99F22F962035

Q30841192-6F377EBB-9C1B-4CC1-8316-6F9EAD78D409

Q30841192-70B274CC-5C79-44FA-B16C-9A047A11AAAD

Q30841192-7ECE0461-C3BA-479A-8B2B-72FBB6B3A264

P2860

Q30841192-0B7F18F5-5C52-4418-A226-FDA5405EEDD1

Q30841192-160DE60F-72C5-464E-A8F1-294855069F91

Q30841192-28636C3B-82F9-446A-A448-C3ABEB07ED24

Q30841192-31856975-61CD-46D5-8FC1-98DAA296FD56

Q30841192-475D5A96-AB58-4E1C-BD1D-5FEF8FEC0AFA

Q30841192-50B2B11F-122F-4615-95E8-60F31E37D2F9

Q30841192-5A93092F-610A-46B5-AD40-489B8DBAEDE6

Q30841192-5DD24218-1B7D-475B-A681-6EA191A54B08

Q30841192-6A5232F0-A7BA-4811-8039-BF37DF2E7786

Q30841192-73B2DB9B-8358-464B-9F9D-AE9C55E4E650

P304

Q30841192-526AE8B4-E822-4B08-AB04-6518BBB082CD

P31

Q30841192-E5B124F7-4814-42BF-83FC-1E166253A85F

P356

Q30841192-DC0F0D80-A9C3-4CF4-B495-4134C2AFB604

P433

Q30841192-0E9F288F-B48E-4B58-B24F-E257D05A6143

P478

Q30841192-88462AF0-4397-4040-A77A-1D54EA6B50D2

P50

Q30841192-1EDDE7A7-18F7-435D-849B-9AC512AA5D44

Q30841192-F0DC5586-04EF-4E69-96E0-D452950374A8

P577

Q30841192-E1D35620-4DB0-4E52-BA2B-83F5B461DCFC

P5875

Q30841192-BCEE98AE-F48C-48D0-803A-DBC1DA105D2B

P698

Q30841192-D108201C-DFD3-4222-9909-8EBB3E0F6DE2

P932

Q30841192-B21E9809-779D-4B85-9807-C0702A5A6439

P356

J.YMGME.2007.12.004

P1433

Molecular Genetics and Metabolism

P1476

Generalized metabolic bone disease in Neurofibromatosis type I

@en

P2093

Alyssa Tran

http://www.w3.org/2001/XMLSchema#string

Brendan Lee

http://www.w3.org/2001/XMLSchema#string

E O'Brian Smith

http://www.w3.org/2001/XMLSchema#string

John Hicks

http://www.w3.org/2001/XMLSchema#string

Kelly Phan

http://www.w3.org/2001/XMLSchema#string

Kenneth J Ellis

http://www.w3.org/2001/XMLSchema#string

Maria Blazo

http://www.w3.org/2001/XMLSchema#string

Richard Alan Lewis

http://www.w3.org/2001/XMLSchema#string

Sharon E Plon

http://www.w3.org/2001/XMLSchema#string

Stephen B Doty

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras

Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions

Z score prediction model for assessment of bone mineral content in pediatric diseases.

The differing tempo of growth in bone size, mass, and density in girls is region-specific

Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body.

Epidemiology of neurofibromatosis type 1.

Neurofibromatosis type 1: A model condition for the study of the molecular basis of variable expressivity in human disorders.

Double inactivation of NF1 in tibial pseudarthrosis.

Diagnosis of osteoporosis in men, premenopausal women, and children.

Bone mineral density in children and adolescents with neurofibromatosis type 1.

P304

105-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2007.12.004

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

Nicola Brunetti-Pierri

Roberto Mendoza-Londono

P577

2008-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5562075

http://www.w3.org/2001/XMLSchema#string

P698

18289904

http://www.w3.org/2001/XMLSchema#string

P932

2430595

http://www.w3.org/2001/XMLSchema#string